NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/BSE_EQ|INE579N01018.png)
SAMSRITA LABS LIMITED Share Price
SAMSRITA
₹17.44+₹1.48 (9.27%) TodayLast updated on 26 Jul, 2024 | 15:27 IST
₹16.31₹18.20
L
H
Company overview
Financial performance
Market cap
| Open₹17.98 | Close₹15.96 |
Circuit range₹20.46 - ₹13.64 | Day range₹16.31 - ₹18.20 | Year range₹13.00 - ₹21.69 |
Volume9,084 | Avg. traded₹17.50 | Revenue (12m)₹0 Crs |
SAMSRITA LABS LIMITEDSamsrita Labs Ltd is an India-based biopharma company. The Company is engaged activities, such as trading, exports and imports, manufacturing of bulk drugs, APIs, Specialty drugs, research and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease.
SAMSRITA LABS LIMITED Key indicators
52 week high₹21.69 | 52 week low₹13.00 | P/E ratio |
P/B ratio1.89 | ROE-5.45% | ROCE-4.59% |
Dividend yield-- | Debt/Equity ratio0.16 | EPS-0.48 |
Learn more
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin-3237.31% | Net profit margin-3260.39% |
ROE-5.45% | ROA-4.3% |
ROCE-4.59% |
Learn more
SAMSRITA LABS LIMITED Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Jul 26 2024 | ₹17.98 | ₹17.05 | |
Thu, Jul 25 2024 | ₹16.99 | ₹15.96 | -6.06% |
Wed, Jul 24 2024 | ₹16.25 | ₹16.99 | -0.82% |
Tue, Jul 23 2024 | ₹17.49 | ₹17.13 | |
Mon, Jul 22 2024 | ₹16.85 | ₹16.82 | |
Fri, Jul 19 2024 | ₹17.86 | ₹16.52 | -0.24% |
Thu, Jul 18 2024 | ₹17.17 | ₹16.56 | -3.55% |
Tue, Jul 16 2024 | ₹18.00 | ₹17.17 | -1.27% |